Process for preparing beta 3 agonists and intermediates

US10696681B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696681-B2
Application numberUS-201916298467-A
CountryUS
Kind codeB2
Filing dateMar 11, 2019
Priority dateMar 15, 2013
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of I-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KRED) biocatalyst enzymes and methods of using the biocatalysts.

First claim

Opening claim text (preview).

What is claimed is: 1. A crystalline form of the HCl salt of Compound I-5(b), wherein Compound I-5(b) has the chemical structure: and wherein the crystalline form is characterized by an XRPD pattern having 2θ peaks at about 8.6°, 13.5°, and 16.7° 20.9°, and 22.7°. 2. The crystalline form of claim 1 , wherein the crystalline form is characterized by an XRPD pattern having 2θ peaks at about 8.6°, 12.9°, 13.5°, 16.7°, 20.9°, 22.7°, and 24.4°. 3. The crystalline form of claim 1 , wherein the crystalline form is characterized by an XRPD pattern having 2θ peaks at about 4.2°, 8.6°, 12.9°, 13.5°, 16.7°, 20.9°, 22.7°, 24.4°, 24.7°, and 28.2°. 4. The crystalline form of claim 1 , wherein the crystalline form is characterized by an XRPD pattern as shown in FIG. 1 . 5. The crystalline form of claim 1 , wherein the crystalline form is characterized by an XRPD pattern having the following reflections with the d-spacing Position [°2 Theta] d-spacing [Å] 4.2174 20.95196 8.5827 10.3028 12.9282 6.84784 13.5177 6.55051 16.65 5.32461 20.9425 4.24193 22.6974 3.91777 24.363 3.65356 24.6986 3.60468 28.1911 3.16555.

Assignees

Inventors

Classifications

  • containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton · CPC title

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms · CPC title

  • Oxygen or sulfur atoms · CPC title

  • Nitrogen as only ring hetero atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696681B2 cover?
The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of I-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KRED) biocatalyst enzymes and methods of using the …
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).